Patents by Inventor Yitao Wang

Yitao Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240187555
    Abstract: A camera view share system is provided. The camera view share system includes a road-side unit. The road-side unit includes a controller configured to receive a request for a bird-eye-view map from an ego vehicle, the bird-eye-view map including a plurality of vehicles, transmit the bird-eye-view map to the ego vehicle, receive a selection of a target vehicle among the plurality of vehicles from the ego vehicle, and transmit a camera feed related to the target vehicle to the ego vehicle.
    Type: Application
    Filed: December 2, 2022
    Publication date: June 6, 2024
    Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., Toyota Jidosha Kabushiki Kaisha
    Inventors: Yitao Chen, Dawei Chen, Haoxin Wang, Kyungtae Han
  • Publication number: 20240174254
    Abstract: A system for communication-aware federated learning includes a server and edge nodes. Each of the edge nodes trains a machine learning model using first local data obtained by sensors of corresponding edge node. Each of the edge nodes obtains network bandwidth for a channel between corresponding edge node and the server. One or more of the edge nodes determines a level of compression based on the bandwidth for the channel, compresses the trained machine leaning model based on the determined level of compression, and transmits the compressed trained machine learning model to the server. The server decompresses the compressed trained machine learning models and aggregates the decompressed trained machine learning models to obtain the aggregated machine learning model, and transmits the aggregated machine learning model to each of the edge nodes. Each of the edge nodes receives the aggregated machine learning model from the server.
    Type: Application
    Filed: November 28, 2022
    Publication date: May 30, 2024
    Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., Toyota Jidosha Kabushiki Kaisha
    Inventors: Yitao Chen, Dawei Chen, Haoxin Wang, Kyungtae Han
  • Publication number: 20240158410
    Abstract: The present invention relates to a Camptothecin compound having anti-tumor activity, a preparation method therefor, and an application thereof. Specifically, the present invention relates to a compound as shown below or a pharmaceutically acceptable form thereof, a pharmaceutical composition thereof, a preparation method therefor, and a use thereof.
    Type: Application
    Filed: January 27, 2022
    Publication date: May 16, 2024
    Applicant: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Qiang TIAN, Yitao ZHANG, Yu MIAO, Bo WANG, Jian YE, Xiaobei WANG, Deliang LI, Fen LI, Hongmei SONG
  • Publication number: 20240127105
    Abstract: A system for contribution-aware federated learning is provided. The system includes a server and a plurality of vehicles. Each of the plurality of vehicles includes a controller programmed to: train a local machine learning model using first local data; obtain metadata for hardware elements of corresponding vehicle; transmit the trained local machine learning model and the metadata to a server; receive an aggregated machine learning model from the server; and train the aggregated machine learning model using second local data. The server generates the aggregated machine learning model based on the trained local machine learning models and the metadata received from the plurality of vehicles.
    Type: Application
    Filed: October 13, 2022
    Publication date: April 18, 2024
    Applicants: Toyota Motor Engineering & Manufacturing North America, Inc., Toyota Jidosha Kabushiki Kaisha
    Inventors: Yitao Chen, Haoxin Wang, Dawei Chen, Kyungtae Han
  • Publication number: 20240116829
    Abstract: Disclosed in the present application are a concrete protection material, and a preparation method and a construction method therefor. The concrete protection material consists of 50%-90% of a component A and 10%-50% of a component B in percentage by weight, where the component A is prepared from 30%-65% of organic silicon, 2%-5% of nano-silicon dioxide and the balance of an organic solvent in percentage by weight; and the component B is prepared from 20%-50% of an organic base and the balance of water in percentage by weight. The present application not only can form nano-particles having a strengthening effect in capillary channels of a concrete surface layer, but also can achieve a technical effect of superhydrophobicity on the concrete surface layer.
    Type: Application
    Filed: November 21, 2022
    Publication date: April 11, 2024
    Applicants: NATIONAL ENGINEERING RESEARCH CENTER OF HIGH-SPEED RAILWAY CONSTRUCTION TECHNOLOGY, CHINA RAILWAY NO.4 ENGINEERING GROUP CO., LTD, ANHUI ENGINEERING MATERIAL TECHNOLOGY CO, LTD OF CTCE GROUP
    Inventors: Dongdong FAN, Hai HUANG, Jianfeng WEN, Jianwei PENG, Zhiyong WANG, Yitao CHEN, Chenhao WU, Jianan YAO, Jie TANG, Juan CHEN, Chunhong LIN, Xianzhu HU, Zhiwu YU
  • Publication number: 20240038325
    Abstract: The application discloses a reverse virtual screening platform and method based on programmable quantum computing, the method includes the following steps: S1, for a given micromolecule and a target protein molecule, calculating a binding interaction graph of the given micromolecule and the target protein molecule on a computer according to different distances between pharmacophores; S2, encoding, according to an adjacency matrix of the binding interaction graph, the binding interaction graph into a quantum reverse virtual screening platform by decomposing the adjacency matrix; and S3, performing Gaussian boson sampling by the quantum reverse virtual screening platform. The reverse virtual screening platform and method based on programmable quantum computing provided by the present application are implemented by an optical quantum computer system based on a time domain.
    Type: Application
    Filed: March 16, 2023
    Publication date: February 1, 2024
    Inventors: Shang YU, Zhipeng ZHONG, Liang XU, Jianshun TANG, Yitao WANG
  • Publication number: 20230381257
    Abstract: An herbal composition including Fructus Terminaliae Chebulae, Radix Paeoniae Lactiflorae, Cortex Magnoliae Officinalis, Rhizoma Corydalis Yanhusuo, Herba Polygoni Chinensis, Rhizoma Atractylodis Macrocephalae, and Semen coicis Lachryrna-jobi useful for treating diseases, such as inflammatory bowel disease, by increasing regulatory T cells in a subject in need thereof, methods for preparing of use and preparation thereof.
    Type: Application
    Filed: May 23, 2023
    Publication date: November 30, 2023
    Inventors: Zhaoxiang BIAN, Ying WANG, YiTao WANG
  • Patent number: 9920088
    Abstract: The present invention relates to the use of triterpenoid derivatives for the preparation of a medicament for preventing or treating influenza diseases, in which the substituents are as defined in the specification. The triterpenoid derivatives of the present invention have obvious inhibition effect on influenza virus, and are capable of obviously preventing influenza virus from entering cells, and can be used for preventing or treating influenza.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: March 20, 2018
    Assignee: University of Macao
    Inventors: Demin Zhou, Maorong Yu, Sulong Xiao, Fei Yu, Yiyun Peng, Yunyan Qiu, Lihe Zhang, Yitao Wang
  • Publication number: 20100286074
    Abstract: The present invention provides a use of ginsenosides represented by formula I or mixtures thereof for manufacturing a medicament for anti-platelet aggregation, wherein R1 and R2 are H or glucosyl, and when R1 is glucosyl, R2 is H; when R1 is H, R2 is glucosyl. The present invention further provides a pharmaceutical composition for anti-platelet aggregation, which is capable to be used to prevent and treat thrombosis. The present invention also provides a method for generating the effect of anti-platelet aggregation in patients in vivo.
    Type: Application
    Filed: May 12, 2008
    Publication date: November 11, 2010
    Applicant: LIMIN PHARMACEUTICAL FACTORY, LIVZON GROUP
    Inventors: Yitao Wang, Shaoping Li, Hui Cao, Zhaohua Peng, Juhua Hu